NCT02254954View on ClinicalTrials.gov

Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma

PHASE1TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 8, 2015

Primary Completion Date

September 29, 2016

Study Completion Date

September 29, 2016

Conditions
Glioblastoma
Interventions
DRUG

Macitentan in combination with RT and TMZ

Escalating doses of macitentan in combination with RT and TMZ, and maintenance TMZ.

Trial Locations (1)

77030

MD Anderson Cancer Center, Houston

Sponsors

Lead Sponsor

Actelion
All Listed Sponsors
lead

Actelion

INDUSTRY

NCT02254954 - Clinical Study on Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed Glioblastoma | Biotech Hunter | Biotech Hunter